New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|September 30, 2015
Supplements and Featured Publications
- Management of Advanced/Metastatic Melanoma: New and Emerging Treatment Pathways, Therapies, and Chal
- Volume 21
- Issue 12 Suppl
Post Test: Management of Advanced/Metastatic Melanoma: New and Emerging Treatment Pathways, Therapies, and Challenges
Advertisement
Pharmacy Credit
Instructions for Receiving Continuing Pharmacy Education (CPE) Credit: Testing and Grading Information
This lesson is free online; receive instant grading and download your CE statement of credit at
Testing and Grading Directions
- Each participant evaluating the activity and achieving a passing grade of 70% or higher on the online posttest will receive a CE statement of credit stating the number of credits earned.
- Participants receiving a failing grade on the exam will be notified and permitted to take 1 reexamination at no cost.
Articles in this issue
Advertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Simple operational changes are proving more effective at closing gaps in cardiovascular-kidney-metabolic (CKM) syndrome care than education campaigns alone, according to panelists at at Population Health Roundtable
Panelists at AJMC roundtables in Philadelphia, Boston, Washington, DC, and Chicago traced why atopic dermatitis stays undertreated despite new therapies.
Eye care access for underserved patients with diabetes is limited and poorly understood. We identified barriers and innovative solutions to improve overall care and establish evidence-based practices.
Patient understanding should be treated as a measurable equity outcome, not an assumed byproduct of care.
The Right Care Initiative provides a proven, scalable framework for reducing preventable cardiovascular deaths. By integrating interorganizational learning, pharmacist-led care, and precision screening (coronary artery calcium imaging), the model bridges the 17-year implementation gap between clinical evidence and improved population health.
Advertisement
Advertisement
Trending on AJMC
1
Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD
2
Across the US, Obesity Care Still Lacks an Owner
3
FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes
4
Aspirin's CRC Benefit Narrows to PIK3CA Exon 9/20 Mutations
5